Today is September 17, 2024.
All times in Eastern Daylight Time.
-
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination With Transarterial Chemoembolization Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma
RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)--KEYTRUDA Plus LENVIMA in Combination With TACE Significantly Improved PFS Compared to TACE Alone in Patients With Unresectable, Non-Metastatic HCC more »
-
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT) Reduced Risk of Death by 33% Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
RAHWAY, N.J.--(BUSINESS WIRE)--Merck’s KEYTRUDA® Plus CRT Reduced Risk of Death by 33% Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer more »
-
Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (GDF-15), met its primar... more »
-
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and safety of BRAFTOVI® (e... more »
-
KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Overall Survival (OS) Versus Trastuzumab and Chemotherapy Alone in First-Line Treatment of Patients With HER2-Positive Advanced Gastric or GEJ Adenocarcinoma
RAHWAY, N.J.--(BUSINESS WIRE)--KEYTRUDA plus trastuzumab and chemotherapy OS results as first-line treatment in patients with HER2-positive advanced gastric or GEJ adenocarcinoma. more »
-
Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced positive po... more »
-
Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024
BARCELONA--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bi... more »
-
Masimo Partners with Google to Develop a Reference Platform That Helps Device Manufacturers Bring High-performing Wear OS Smartwatches to Market
IRVINE, Calif.--(BUSINESS WIRE)--Masimo announced a partnership with Google to develop a comprehensive smartwatch reference platform for OEMs building Wear OS by Google smartwatches. more »
-
SCF Acquires Newpark Fluids Systems
HOUSTON--(BUSINESS WIRE)--SCF Partners, Inc. (“SCF”) is pleased to announce its acquisition of the Newpark Fluids Systems business (“NFS”), a leading global pure-play oil & gas and geothermal f... more »
-
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinic... more »
-
CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clini... more »
-
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Aviat Networks, Inc. (AVNW)
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Aviat Networks, Inc. (“Aviat” or the “Company”) (NASDAQ: AVNW). The investigation concerns w... more »
-
Masimo Issues Statement Following Court’s Order Holding Politan and Quentin Koffey in Contempt and Finding Politan Made False Statements to Stockholders
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today issued a statement f... more »
-
Jack Nathan Health Signs Letter of Intent
TORONTO--(BUSINESS WIRE)--Jack Nathan Medical Corp. (TSXV: “JNH”; OTCQB: “JNHMF”) (the “Company”) announces that, further to recent Company press releases reporting that the Company will be explori... more »
-
Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, is pleased to announce the... more »
-
CAE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against CAE, Inc. - CAE
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 16,... more »
-
Caesars Sportsbook Becomes First to Accept In-person Sports Wagers in Maine Through Partnership with First Tracks Investments LLC
PORTLAND, Maine--(BUSINESS WIRE)--Caesars Entertainment, Inc. (NASDAQ: CZR) (“Caesars”) today celebrated the first in-person sports wagering location in the state of Maine at the newly opened sport... more »
-
HF Sinclair Corporation Third Quarter 2024 Earnings Release and Conference Webcast
DALLAS--(BUSINESS WIRE)--HF Sinclair Corporation (NYSE: DINO) (“HF Sinclair”) plans to announce results for the quarter ending September 30, 2024, on October 31, 2024, before the opening of trading... more »
-
Hamilton ETFs Launches Hamilton U.S. T-Bill YIELD MAXIMIZER™ ETF
TORONTO--(BUSINESS WIRE)--Hamilton ETFs Launches Hamilton U.S. T-Bill YIELD MAXIMIZER™ ETF more »
-
UNITEDHEALTH GROUP INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of UnitedHealth Group Incorporated - UNH
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an ... more »
-
Gores Holdings IX Announces Receipt of Nasdaq Listing Delinquency Notification Letter
BOULDER, Colo.--(BUSINESS WIRE)--Gores Holdings IX, Inc. (Nasdaq: GHIX) (the “Company”) today announced that it received a delinquency notification letter (the “Notice”) from the Nasdaq Listing Qua... more »
-
bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-Q
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has completed the restatement of its consolidated financial statements for the year ended December 31, ... more »
-
Focus Impact Acquisition Corp. Shareholders Approve Previously Announced Business Combination with DevvStream
NEW YORK--(BUSINESS WIRE)--DevvStream Holdings Inc. (“DevvStream” or the “Company”) (CBOE: DESG) (OTCQB: DSTRF) (FSE: CQ0), a leading carbon credit project co-development and generation firm specia... more »
-
KKR Real Estate Finance Trust Inc. Declares Quarterly Dividend of $0.25 Per Share of Common Stock
NEW YORK--(BUSINESS WIRE)--KKR Real Estate Finance Trust Inc. (the “Company” or “KREF”) (NYSE: KREF) announced that the Board of Directors has declared a dividend of $0.25 per share of common stock... more »
-
BlackRock Municipal Income Fund, Inc. (MUI) Announces Variable Rate Demand Preferred Shares Action
NEW YORK--(BUSINESS WIRE)--BlackRock Advisors, LLC today announced BlackRock Municipal Income Fund, Inc. (NYSE: MUI, the “Fund”, CUSIP: 09253X102) intends to redeem all of its outstanding Series W-... more »
|
|